Advertisement

Topics

The Alpha-1 Project Company Profile

09:30 EDT 18th September 2018 | BioPortfolio

Mission statement: The Alpha-1 Project will work with patients, academia, pharmaceutical and biotech companies, and public health organizations in the relentless pursuit of cures and therapies for COPD and liver disease caused by Alpha-1 Antitrypsin Deficiency. For more information, visit www.thealpha-1project.com. The Alpha-1 Project is a wholly-owned for-profit subsidiary of the Alpha-1 Foundation. For more information on the Foundation, visit www.alpha-1foundation.org.


News Articles [547 Associated News Articles listed on BioPortfolio]

Radiation cancer therapy co Alpha Tau Medical raises $29m

Alpha DaRT enables the first alpha-radiation-based cancer treatment for various types of solid tumors.

BU medical student receives student fellowship from Alpha Omega Alpha

(Boston University School of Medicine) Melissa Chua, a fourth-year medical student at Boston University School of Medicine (BUSM), has received the Alpha Omega Alpha (AOA) Carolyn L. Kuckein Student R...

Israeli radiation therapy firm Alpha Tau raises $29 million

Alpha Tau Medical, an Israeli developer of alpha radiation cancer therapy, said on Wednesday it raised $29 million in a private financing round led by private equity firm Shavit Capital.

Alpha Tau Medical gets $29M boost

A round of financing has brought in $29 million for Israel-based Alpha Tau Medical, which is developing technology called Alp -More- 

Kamada Received Feedback from FDA on Proposed Phase 3 Protocol for Inhaled Alpha-1-Antitrypsin for Treatment of Alpha-1 Antitrypsin Deficiency Disease

REHOVOT, Israel, April 23, 2018 (GLOBE NEWSWIRE) -- Kamada Ltd. (the "Company") (Nasdaq:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company, today announced that the Company recentl...

Mass. agency OKs Alpha Tau's cancer-zapping device for use in trials

The Massachusetts Radiation Control Program has granted Israel-based Alpha Tau Medical a Sealed Source and Device approval fo -More- 

Alpha Genesis wins $1m contract to support progressive brain disorder research

The multi-year project with an unnamed pharmaceutical company will use the macaque monkey as a developmental model for progressive brain disorders and is valued at more than $1m.

Pharnext veröffentlicht Ergebnisse für das Geschäftsjahr 2017

Pharnext SA (Paris:ALPHA) (FR00111911287 ALPHA), ein französisches biopharmazeutisches Unternehmen und Pionier eines neuen Ansatzes zur Entwicklung innovativer Arzneimittelkombinationen auf der Ba...

Drugs and Medications [159 Associated Drugs and Medications listed on BioPortfolio]

Isa knox x2d2 wrinkle serum [LG Household and Healthcare, Inc.]

Drug Facts

Doxazosin [Apotex Corp.]

DOXAZOSIN TABLETS, USP 1 mg, 2 mg, 4 mg and 8 mg

Cardura [Roerig]

CARDURA® (doxazosin mesylate) Tablets

Doxazosin mesylate [Golden State Medical Supply, Inc.]

DOXAZOSIN MESYLATE TABLETS, USP

Doxazosin mesylate [Major Pharmaceuticals]

DOXAZOSIN MESYLATE TABLETS

PubMed Articles [898 Associated PubMed Articles listed on BioPortfolio]

Basophil Activation Test Differentiates Between Patients with Alpha-Gal Syndrome and Asymptomatic Alpha-Gal Sensitization.

The alpha-gal syndrome is characterized by the presence of sIgE antibodies to alpha-gal and delayed type I allergic reaction to the carbohydrate galactose-alpha-1,3-galactose (alpha-gal) after consump...

Using the Logic Model Framework to Standardize Quality and Rigor in the DNP Project.

Since the implementation of the DNP degree, there has been controversy, confusion, and inconsistency about the DNP project. To this day, the profession lacks a consensus of what the DNP project should...

The project vita: A dynamic knowledge management tool.

A project vita is a comprehensive index of factual information about a project's activities and achievements. Like an individual's professional curriculum vita or resume, it serves as evidence of past...

Detection of alpha radionuclides in air from patients during Ra-223 alpha radionuclide therapy.

Ra-223 has recently been introduced to alpha radionuclide therapy. According to the decay scheme of Ra-223, an inert gas, Rn-219 is released from patients during alpha radionuclide therapy and its dau...

Longterm Homecare Augmentation Program in Alpha-1-Antitrypsin Deficient Patients.

Augmentation with human alpha-1 proteinase inhibitor is the only specific treatment for Alpha-1-Antitrypsin Deficiency (AATD), a rare genetic disease with symptoms of progressive COPD.

Clinical Trials [2903 Associated Clinical Trials listed on BioPortfolio]

Thymosin Alpha 1, Interferon Alpha, or Both, in Combination With Dacarbazine in Patients With Malignant Melanoma

The purpose of the study is to test safety and efficacy of different doses of thymosin alpha 1 (1.6 mg, 3.2 mg, and 6.4 mg) in combination with dacarbazine and with or without Interferon a...

The Safety and Tolerability of Alpha-1 MP In Subjects With Alpha-1-Antitrypsin (AAT) Deficiency

The purpose of this clinical study is to assess the safety and tolerability of Alpha-1 MP in adult Alpha1-antitrypsin deficient patients.

Alpha-1 Foundation Research Registry

The Alpha-1 Foundation Research Registry is a confidential database made up of individuals diagnosed with severe alpha-1 antitrypsin deficiency (Alpha-1) or the carrier state.

Alpha MSH in Ocular Disease

The purpose of this study is gain a better understanding of a molecule called alpha melanocyte stimulating hormone (alpha MSH) and its potential role in your retinal disease. Alpha MSH has...

Dose Finding Study of Recombinant Human Alpha-mannosidase for the Treatment of Patients With Alpha-mannosidosis

This is a single-center, open-label, multiple-dose study of the efficacy and long-term safety of Lamazym for the treatment of patients with alpha-mannosidosis.

Companies [818 Associated Companies listed on BioPortfolio]

The Alpha-1 Project

Mission statement: The Alpha-1 Project will work with patients, academia, pharmaceutical and biotech companies, and public health organizations in the relentless pursuit of cures ...

Alpha-1 Foundation

The mission of the Alpha-1 Foundation is to provide the leadership and resources that will result in increased research, improved health, worldwide detection, and a cure for Alpha...

Alpha-1 Foundation and Foundation for Sarcoidosis Research

The mission of the Alpha-1 Foundation is to provide the leadership and resources that will result in increased research, improved health, worldwide detection, and a cure for Alpha...

Alpha-Stim

Alpha-Stim is an industry leader in cranial electrotherapy stimulation (CES) devices, providing treatment for anxiety, depression, insomnia and pain, without the side effects comm...

Alpha Pro Tech, Ltd.

Alpha Pro Tech, Ltd. is the parent company of Alpha Pro Tech, Inc., and Alpha ProTech Engineered Products, Inc. Alpha Pro Tech, Inc. develops, manufactures and markets innovative ...

More Information about "The Alpha-1 Project" on BioPortfolio

We have published hundreds of The Alpha-1 Project news stories on BioPortfolio along with dozens of The Alpha-1 Project Clinical Trials and PubMed Articles about The Alpha-1 Project for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Alpha-1 Project Companies in our database. You can also find out about relevant The Alpha-1 Project Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

COPD (chronic obstructive pulmonary disease)
COPD (chronic obstructive pulmonary disease) is used for a number of conditions including chronic bronchitis and emphysema, which all  lead to the airways in the lungs becoming damaged and thus narrower,  making inhalation and exhalation harder...


Corporate Database Quicklinks



Searches Linking to this Company Record